A second pattern was seen in 2 of the 9 infants treated with either IGF-1 or GDNF studied thus far, where there was a relatively rapid decrease in their exotropia within the first 2–4 weeks, followed by an increase in strabismus angle between 2 and 3 months. The gene discussed is IGF1; the disease is Exotropia.